Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
amglidia
ammtek - glibenclamide - diabetes mellitus - drogi użati fid-dijabete - amglidia huwa indikat għall-kura ta ' trabi tat-twelid dijabete mellitus, għall-użu fit-trabi tat-twelid, trabi u tfal. sulphonylureas bħal amglidia ntwerew li huma effikaċi fil-pazjenti bil-mutazzjonijiet fil-kodiċi tal-ġene għall-taċ-ċelloli β-potassju sensittiv għal atp kanal u tal-kromożomi 6q24 relatati mal-għaddiena neonatali tad-dijabete mellitus.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
semglee
viatris limited - insulina glargine - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sentejn u aktar.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
insulin aspart sanofi
sanofi winthrop industrie - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
kirsty (previously kixelle)
biosimilar collaborations ireland limited - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.